Does Wegovy Have Long-Term Side Effects? What the Evidence Says

Step 1 — The first weeks: the side effects most people notice

The opening phase of Wegovy treatment is the period when side effects are most noticeable. Nausea is the most commonly reported, followed by diarrhoea, constipation, indigestion, burping and, less often, vomiting. If you want a thorough answer to whether Wegovy has any side effects and what they actually involve, our dedicated page covers the full picture, but the short version is this: they are GI-led, usually mild to moderate, and in most people they settle within days to a couple of weeks.

The dose titration schedule that prescribers follow (starting low and stepping up every four weeks) exists precisely to give the body time to adjust. For people who do experience persistent nausea, it often improves once the body has been at a given dose for a few weeks. Our clinical team takes tolerability seriously; any decision to increase a dose is a clinical one, not automatic.

Injection-site reactions (redness, bruising, mild swelling at the injection site) can also occur, though these are generally short-lived. Headaches and fatigue are reported too, often in the early period. Worth keeping in the fridge door next to the pen: a note of any symptoms you notice, with approximate dates, so you have something useful to share with your prescriber.

Step 2, Months into treatment: the effects that persist or emerge later

A smaller group of people experience side effects that don't fully resolve. Constipation, in particular, can linger for some people throughout treatment, and managing fibre and fluid intake alongside the medicine becomes part of everyday routine. Gastrointestinal symptoms that reappear after a dose increase are also common, they are not necessarily a sign that the medicine is less well tolerated long-term, just that the body is readjusting.

The concern that clinical studies have flagged more consistently over longer durations is gallbladder disease. In the STEP 1 trial, published in the New England Journal of Medicine, gallbladder-related events occurred more often in the semaglutide group than placebo. The mechanism is likely linked to rapid weight loss itself, which can increase bile concentration, and is not unique to Wegovy. Your prescriber can discuss whether you have any personal risk factors worth considering.

There is also an ongoing question about bone density and muscle mass during significant weight loss. Current evidence does not establish a direct long-term harm from semaglutide specifically, but preserving muscle through adequate protein and regular resistance activity is advice that appears consistently in NHS guidance on weight management medicines. Our page on the side effects of long-term Wegovy use covers this area in more depth, including why it remains an active area of monitoring.

Step 3, When to get medical help without delay

Most side effects can be managed or monitored in routine aftercare. Some cannot wait. The MHRA's Drug Safety Update published in January 2026 specifically highlighted acute pancreatitis as a known but infrequent risk with GLP-1 medicines. Severe, persistent stomach pain that radiates to the back, with or without vomiting, needs urgent medical attention. Stop the medicine and seek help the same day.

Other symptoms that warrant prompt contact with a healthcare professional include: signs of a serious allergic reaction (difficulty breathing, swelling of the face or throat, a rapid heartbeat); gallbladder symptoms such as upper-right abdominal pain, fever or jaundice; and any symptoms of severe dehydration following persistent vomiting or diarrhoea, which can place strain on the kidneys. Sudden changes to vision should also be raised with a doctor without delay, particularly for anyone with underlying diabetes.

For a fuller picture of what side effects Wegovy can cause, including which are common versus rare, the NHS medicines page for semaglutide is the clearest UK-facing resource. If you are on treatment through nume, our aftercare team is available seven days a week through our contact page.

Step 4, After stopping: what longer-term effects look like off treatment

One of the most clinically significant long-term questions about Wegovy is what happens when treatment ends. The STEP 1 trial follow-up data showed that much of the weight lost during treatment returned within a year of stopping, which tells us something important: this is a medicine for an ongoing condition, not a finite course in the way antibiotics are. Weight regain after stopping is not a side effect in the pharmacological sense, but it is a consequence that matters clinically and practically.

There is no established evidence that Wegovy causes lasting physiological harm in people who stop, and our page on what the long-term side effects of Wegovy are explores this question in detail, including what the current evidence does and does not show. The question of whether appetite hormones reset fully over time is still being studied. If you are thinking about treatment or wondering how it fits your circumstances, our weight-loss treatment overview explains the options our prescribers assess, and a consultation gives you the space to talk this through properly.

On the question of less common or comparison-specific effects, our page on how Wegovy's side-effect profile compares covers the data more directly. If you have a question our FAQs don't answer, our dedicated Wegovy side effects page brings together the information most people find useful, and the general FAQs page is a good starting point for anything else. For people ready to speak with a prescriber, the consultation is free, covers suitability and side effects in full, and our prescribers discuss all of this as part of the assessment, not as an afterthought. Start your free consultation when you're ready.